The 4th International Biopharmaceutical Industry Development Innovation Forum  

April 21-22, 2011 | Shanghai Pudong, China

The 4^th International Biopharmaceutical Industry Development Innovation Forum & International Innovative drug research and translational medicine Summit, organized by Sino-EU Chemical Manufacturers Association Biomedical Committee（SEBMC),  will be held on Apr. 21^st -22^nd, 2011 at Renaissance Shanghai Pudong Hotel. At that time, more than 400 representatives and experts from the USA, Europe, China, Asia-pacific and international leading drug and medical specialists who engage on biopharmaceuticals, new drug research, innovative drug CRO, clinical medicine R&D and translational medicine will attend. This forum will focus on global Innovative bio-pharmaceutical R&D innovation and human health, the antibody-based drugs, new vaccines, genetic engineering drugs, antibody humanization technology, new drug development technology, recombinant human protein, gene therapy, cell therapy and interferon and the development and application of medical innovation, anti-infection drugs, anti-diabetic drugs and the cardiovascular system drugs, nervous system drugs, anti-drug discovery and treatment of major diseases, drug discovery, drug design, drug clinical trials, patents and licensing, innovation and outsourcing of drug and clinical trials cooperation in Asia and biopharmaceutical industry development. 

The 11th annual World Vaccine Congress Washington  

April 11-14, 2011 | Washington DC, USA

As industry continues to re-address the scientific and strategic boundaries of vaccine development, the implications for how these pioneering advances impact domestic and international immunization and market growth are profound.

In 2010 over 485+ delegates came to the 10th annual World Vaccine Congress Washington! In 2011 you will have the opportunity to hear from North America’s leading governmental stakeholders, business leaders and scientific stakeholders as they continue to enhance the scientific and strategic innovation behind a burgeoning vaccine industry.